PHQ-9 Score (Patient Health Questionnaire)
A clinical screening and diagnostic tool for measuring the severity of depression based on DSM-IV criteria.
The PHQ-9 Score: The Gold Standard for Depression Screening
The Patient Health Questionnaire-9 (PHQ-9) is an internationally validated clinical self-assessment instrument utilized for the screening, diagnosis, and monitoring of Major Depressive Disorder (MDD). Developed by Drs. Kroenke, Spitzer, and Williams, it is distinguished by its conciseness (comprising only 9 items) and its direct correlation with the diagnostic criteria established in the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders). In primary care and psychiatric settings, it has become the definitive tool to rapidly identify patients requiring therapeutic intervention.
Clinical Utility and Sensitivity of the PHQ-9
Depression remains a leading cause of functional disability globally, yet it is frequently underdiagnosed in outpatient settings. The PHQ-9 provides a sensitivity of 88% and a specificity of 88% for detecting major depression when using a threshold score of ≥ 10. Its systematic implementation allows healthcare providers to quantify symptom severity and its impact on the patient's daily functioning. A significant clinical advantage of the PHQ-9 is its efficacy in measuring treatment response: a reduction of 5 points from the baseline score indicates a clinically significant improvement, whereas a score below 5 generally represents clinical remission.
Absolute Emergency: Question 9
The ninth item of the questionnaire, which inquires about thoughts of death or self-harm, is a critical predictor of suicidal risk. Any positive response to this item (a score > 0) mandates an immediate and thorough clinical evaluation by a healthcare professional, regardless of the patient's total score. The clinician must systematically explore the patient's intent, suicidal planning, and access to lethal means to implement immediate safety protocols and potential hospitalization.
Interpretation Grid and Clinical Recommendations
| Total Score | Depression Severity | Clinical Action |
|---|---|---|
| 0 – 4 | Minimal or None | No active treatment required. |
| 5 – 9 | Mild Depression | Watchful waiting; repeat PHQ-9 at follow-up. |
| 10 – 14 | Moderate Depression | Consider psychotherapy and/or pharmacotherapy. |
| 15 – 19 | Moderately Severe | Active treatment with pharmacotherapy and/or psychotherapy. |
| 20 – 27 | Severe Depression | Immediate initiation of pharmacotherapy and expedited psychiatric referral. |
Scientific References:
1. Kroenke K, et al. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.
2. Spitzer RL, et al. Validation and utility of a self-report version of PRIME-MD: the PHQ modules. JAMA. 1999.
3. Manea L, et al. Optimal cut-off scores for identifying depression with the PHQ-9. BJPsych 2012.
-
💡 Committed to scientific accuracy, if you notice any clinical or technical discrepancy, please let us know.